Role of ambulatory blood pressure monitoring in the management of hypertension

American Journal of Health-System Pharmacy

Volumn 65, Issue 3, 2008, Pages 209-218

  Chavanu, Kathleen ^a   Merkel, Jennifer ^a   Quan, Allen M ^a  

^a DAIICHI SANKYO INC   (United States)

Author keywords

Blood pressure; Hypertension; Hypotensive agents; Tests

Indexed keywords

AMBULATORY MONITORING; AUTOMATION; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; HUMAN; HYPERTENSION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT PLANNING;

BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION;

EID: 38749151977     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp060663     Document Type: Review

References (89)

1. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42:1206-52.
2. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000; 160:2281-6.
3. Mancia G, Sega R, Bravi C et al. Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995; 13:1377-90.
4. Stergiou GS, Efstathiou SP, Skeva II et al. Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ambulatory measurements. J Hum Hypertens. 2002; 16:729-35.
5. Cushman WC, Basile J. Achieving blood pressure goals: why aren't we? J Clin Hypertens. 2006; 8:865-72.
6. Morgan T, Anderson A. How important is 24-hour control of blood pressure? Drug Saf. 1996; 15:243-8.
7. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit. 2001; 6:63-72.
8. Marchiando RJ, Elston MP. Automated ambulatory blood pressure monitoring: clinical utility in the family practice setting. Am Fam Physician. 2003; 67:2343-50.
9. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006; 354:2368-74.
10. Staessen JA, Beilin L, Parati G et al. Task force IV: clinical use of ambulatory blood pressure monitoring. Blood Press Monit. 1999; 4:319-31.
11. Sokolow M, Werdegar D, Kain HK et al. Relationship between level of blood pressure measured casually and by portable recorders and severity of complications in essential hypertension. Circulation. 1966; 34:279-98.
12. Sica DA. Ambulatory blood pressure monitoring in 2005. Medscape Cardiol. 2005; 9.
13. O'Brien E, Coats A, Owens P et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ. 2000; 320:1128-34.
14. Elliott HL. 24-hour blood pressure control: its relevance to cardiovascular outcomes and the importance of long-acting antihypertensive drugs. J Hum Hypertens. 2004; 18:539-43.
15. Myers MG. Ambulatory blood pressure monitoring: a proposal for new Canadian guidelines. Can J Cardiol. 1999; 15:7C-12C.
16. Myers MG, Haynes RB, Rabkin SW. Canadian Hypertension Society guidelines for ambulatory blood pressure monitoring. Am J Hypertens. 1999; 12:1149-57.
17. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens. 1999; 17:151-83.
18. Feldman RD, Campbell N, Larochelle P et al. 1999 Canadian recommendations for the management of hypertension. CMAJ. 1999; 161(suppl 12):S1-17.
19. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996; 9:1-11.
20. Prasad N, Isles C. Ambulatory blood pressure monitoring: a guide for general practitioners. BMJ. 1996; 313: 1535-41.
21. McGrath BP. Ambulatory blood pressure monitoring. Med J Aust. 2002; 176: 588-92.
22. Pickering TG, Hall JE, Appel LJ et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005; 45:142-61.
23. Pater C. Beyond the evidence of the new hypertension guidelines. Blood pressure measurement - is it good enough for accurate diagnosis of hypertension? Time might be in, for a paradigm shift (I). Curr Control Trials Cardiovasc Med. 2005; 6:6.
24. Pater C. The blood pressure "uncertainty range" - a pragmatic approach to overcome current diagnostic uncertainties (II). Curr Control Trials Cardiovasc Med. 2005; 6:5.
25. White WB. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monit. 1997; 2:47-51.
26. Silagy CA, McNeil JJ, Farish S et al. Comparison of repeated measurement of ambulatory and clinic blood pressure readings in isolated systolic hypertension. Clin Exp Hypertens. 1993; 15:895-909.
27. Obara T, Ohkubo T, Kikuya M et al. Prevalence of masked uncontrolled and treated white-coat hypertension defined according to the average of morning and evening home blood pressure value: from the Japan Home versus Office Measurement Evaluation Study. Blood Press Monit. 2005; 10:311-6.
28. Pierdomenico SD, Mezzetti A, Lapenna D et al. 'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J. 1995; 16:692-7.
29. Segre CA, Ueno RK, Warde KR et al. White-coat hypertension and normotension in the League of Hypertension of the Hospital das Clinicas, FMUSP: prevalence, clinical and demographic characteristics. Arq Bras Cardiol. 2003; 80:117-26.
30. Helvaci MR, Seyhanli M. What a high prevalence of white coat hypertension in society! Intern Med. 2006; 45:671-4.
31. Amado P, Vasconcelos N, Santos I et al. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect."] Rev Port Cardiol. 1999; 18:897-906. In Portuguese.
32. Bobrie G, Chatellier G, Genes N et al. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA. 2004; 291:1342-9.
33. Pickering TG, Davidson K, Gerin W et al. Masked hypertension. Hypertension. 2002; 40:795-6. Editorial.
34. Birkett NJ. The effect of alternative criteria for hypertension on estimates of prevalence and control. J Hypertens. 1997; 15:237-44.
35. Reeves RA. The rational clinical examination. Does this patient have hypertension? How to measure blood pressure. JAMA. 1995; 273:1211-8.
36. Kleinert HD, Harshfield GA, Pickering TG et al. What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension. 1984; 6:574-8.
37. Staessen JA, Byttebier G, Buntinx F et al. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement: a randomized controlled trial. JAMA. 1997; 278: 1065-72.
38. Staessen JA, Fagard RH, Lijnen PJ et al. Mean and range of the ambulatory pressure in normotensive subjects from a meta-analysis of 23 studies. Am J Cardiol. 1991; 67:723-7.
39. Alagiakrishnan K, Masaki K, Schatz I et al. Blood pressure dysregulation syndrome. The case for control throughout the circadian cycle. Geriatrics. 2001; 56:50-2,55-6,59-60.
40. Clement DL, De Buyzere ML, De Bacquer DA et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003; 348:2407-15.
41. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983; 249:2792-8.
42. Redon J, Campos C, Narciso ML et al. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension. 1998; 31:712-8.
43. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000; 35:844-51.
44. Bastos JM, Bertoquini S, Silva JA et al. Relationship between ambulatory blood pressure monitoring values and future occurrence of ischemic cerebrovascular and coronary events in hypertensive patients. Rev Port Cardiol. 2006; 25:305-16.
45. Dolan E, Stanton A, Thijs L et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005; 46:156-61.
46. Hirotsu C, Ohta E, Hirose N et al. Profile analysis of 24-hours measurements of blood pressure. Biometrics. 2003; 59:907-15.
47. Chughtai I, Peixoto A. Ambulatory blood pressure monitoring: a review of its clinical and prognostic relevance. Hosp Phys. 2003; 39:47-62.
48. Staessen JA, Thijs L, Fagard R et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999; 282:539-46.
49. Fagard R, Bielen E, Amery A. Automated versus observer blood pressure as determinants of left ventricular structure. Eur Heart J. 1992; 13:1373-9.
50. Schulte KL, Liederwald K, Meyer-Sabellek W et al. Relationships between ambulatory blood pressure, forearm vascular resistance, and left ventricular mass in hypertensive and normotensive subjects. Am J Hypertens. 1993; 6:786-93.
51. Cuspidi C, Meani S, Lonati L et al. Short-term reproducibility of a non-dipping pattern in type 2 diabetic hypertensive patients. J Hypertens. 2006; 24:647-53.
52. Staessen JA, Den Hond E, Celis H et al. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. JAMA. 2004; 291:955-64.
53. Herpin D, Pickering T, Stergiou G et al. Consensus conference on self-blood pressure measurement. Clinical applications and diagnosis. Blood Press Monit. 2000; 5:131-5.
54. Gardner SF, Schneider EF. 24-hour ambulatory blood pressure monitoring in primary care. J Am Board Fam Pract. 2001; 14:166-71.
55. Mallion JM, Baguet JP, Siche JP et al. Clinical value of ambulatory blood pressure monitoring. J Hypertens. 1999; 17:585-95.
56. White WB. Guidelines on the clinical utility of ambulatory blood pressure. Blood Press Monit. 1998; 3:181-4.
57. Mengden T, Vetter H, Tisler A et al. Telemonitoring of home blood pressure. Blood Press Monit. 2001; 6:185-9.
58. Rogers MA, Small D, Buchan DA et al. Home monitoring service improves mean arterial pressure in patients with essential hypertension: a randomized, controlled trial. Ann Intern Med. 2001; 134:1024-32.
59. ICH Steering Committee. Principles for clinical evaluation of new antihypertensive drugs: draff ICH consensus principle. www.fda.gov/cder/ guidance/3774dft.pdf (accessed 2006 Jul 18).
60. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertension. 2006; 47:29-34.
61. Yarows SA, Khoury S, Sowers JR. Cost effectiveness of 24-hour ambulatory blood pressure monitoring in evaluation and treatment of essential hypertension. Am J Hypertens. 1994; 7:464-8.
62. Rodriguez-Roca GC, Alonso-Moreno FJ, Garcia-Jimenez A et al. Cost-effectiveness of ambulatory blood pressure monitoring in the follow-up of hypertension. Blood Press. 2006; 15:27-36.
63. Aitken L, Addison C. The cost-effectiveness of ambulatory blood pressure monitoring. Prof Nurse. 1996; 12:198-202.
64. Wing LM, Brown MA, Beilin LJ et al. 'Reverse white-coat hypertension' in older hypertensives. J Hypertens. 2002; 20:639-44.
65. O'Sullivan C, Duggan J, Lyons S et al. Hypertensive target-organ damage in the very elderly. Hypertension. 2003; 42:130-5.
66. Cicconetti P, Morelli S, Ottaviani L et al. Blunted nocturnal fall in blood pressure and left ventricular mass in elderly individuals with recently diagnosed isolated systolic hypertension. Am J Hypertens. 2003; 16:900-5.
67. Pinto E, Bulpitt C, Beckett N et al. Rationale and methodology of monitoring ambulatory blood pressure and arterial compliance in the Hypertension in the Very Elderly Trial. Blood Press Monit. 2006; 11:3-8.
68. Leitao CB, Canani LH, Kramer CK et al. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care. 2007; 30:1255-60.
69. Lengyel Z, Rosivall L, Nemeth C et al. Diurnal blood pressure pattern may predict the increase of urinary albumin excretion in normotensive normoalbuminuric type 1 diabetes mellitus patients. Diabetes Res Clin Pract. 2003; 62:159-67.
70. Carmona J, Amado P, Vasconcelos N et al. Prognostic markers in treated hyperten-sive diabetic patients. 28-month follow-up. Rev Port Cardiol. 2004; 23:1119-35.
71. Mannucci E, Lambertucci L, Monami M et al. Pulse pressure and mortality in hypertensive type 2 diabetic patients: a cohort study. Diabetes Metab Res Rev. 2006; 22:172-5.
72. Prakash S, Chibber SK, Prakash S et al. Assessment of hypertension control in chronic kidney disease patients by ambulatory blood pressure monitoring. J Assoc Physicians India. 2005; 53:769-74.
73. Jacob P, Hartung R, Bohlender J et al. Utility of 24-h ambulatory blood pressure measurement in a routine clinical setting of patients with chronic renal disease. J Hum Hypertens. 2004; 18:745-51.
74. Liu M, Takahashi H, Morita Y et al. Non-dipping is a potent predictor of cardiovascular mortality and is associated with autonomic dysfunction in haemodialysis patients. Nephrol Dial Transplant. 2003; 18:563-9.
75. Martinez Castelao A, Ibernon M, Sarrias X et al. Doxazosin GITS trough to peak ratio and 24-hour blood pressure monitoring in the management of hypertension in renal transplant patients. Transplant Proc. 2003; 35:1736-8.
76. Marcondes AM, De Lima JJ, Giorgi DM et al. Twenty-four hour blood pressure profile and left ventricular hypertrophy early after renal transplantation. Ren Fail. 2002; 24:207-13.
77. Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens. 2001; 14:1263-9.
78. Muxfeldt ES, Bloch KV, Nogueira AR et al. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit. 2003; 8:181-5.
79. Nogueira Ada R, Fernandes AS, Coutinho ES et al. Factors associated with microalbuminuria in resistant hypertension. Int J Cardiol. 2007; 121:86-7.
80. Aylett MJ. Ambulatory or self blood pressure measurement? Improving the diagnosis of hypertension. Fam Pract. 1994; 11:197-200.
81. Ernst ME, Bergus GR. Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey. BMC Fam Pract. 2003; 4:15.
82. Carney S, Gillies A, Garvey L et al. Direct comparison of repeated same-day self and ambulatory blood pressure monitoring. Nephrology. 2005; 10:151-6.
83. Palatini P. Limitations of ambulatory blood pressure monitoring. Blood Press Monit. 2001; 6:221-4.
84. Hornung RS, Gould BA, Kieso H et al. The effect of a combination of timolol, hydrochlorothiazide and amiloride on 24 hour blood pressure control using ambulatory intra-arterial monitoring. Br J Clin Pharmacol. 1982; 14:415-20.
85. Neutel JM, Smith DH, Weber MA. Low dose combination therapy vs. high dose monotherapy in the management of hypertension. J Clin Hypertens. 1999; 1:79-86.
86. Antonicelli R, Omboni S, Giovanni DC et al. Smooth blood pressure control obtained with extended-release felodipine in elderly patients with hypertension: evaluation by 24-hour ambulatory blood pressure monitoring. Drugs Aging. 2002; 19:541-51.
87. Lacourciere Y, Lenis J, Orchard R et al. A comparison of the efficacies and duration of action of the angiotensin II receptor blockers telmisartan and amlodipine. Blood Press Monit. 1998; 3:295-302.
88. Neutel JM. Use of ambulatory blood pressure monitoring to evaluate the selective angiotensin II receptor antagonist, telmisartan, and other antihypertensive drugs. Blood Press Monit. 2000; 5(suppl 1):S35-40.
89. Chrysant S, Marbury T, Silfani TN. Use of 24-hour ambulatory blood pressure monitoring to assess blood pressure control: a comparison of olmesartan medoxomil and amlodipine besylate. Blood Press Monit. 2006; 11:135-41.